Logo image of CHSCO

CHS INC - CHSINC 7 7/8 PERP (CHSCO) Stock Fundamental Analysis

USA - NASDAQ:CHSCO - US12542R3084

26.48 USD
+0.04 (+0.15%)
Last: 10/16/2025, 4:30:01 PM
Fundamental Rating

3

CHSCO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 87 industry peers in the Food Products industry. While CHSCO is still in line with the averages on profitability rating, there are concerns on its financial health. CHSCO has a expensive valuation and it also scores bad on growth. Finally CHSCO also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CHSCO had a positive cash flow from operations.
CHSCO had positive earnings in each of the past 5 years.
In the past 5 years CHSCO always reported a positive cash flow from operatings.
CHSCO Yearly Net Income VS EBIT VS OCF VS FCFCHSCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

The Return On Assets of CHSCO (2.61%) is comparable to the rest of the industry.
With a Return On Equity value of 4.76%, CHSCO perfoms like the industry average, outperforming 50.57% of the companies in the same industry.
With a Return On Invested Capital value of 0.05%, CHSCO is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for CHSCO is significantly below the industry average of 28.34%.
The 3 year average ROIC (6.11%) for CHSCO is well above the current ROIC(0.05%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROIC 0.05%
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
CHSCO Yearly ROA, ROE, ROICCHSCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CHSCO has a Profit Margin of 1.42%. This is comparable to the rest of the industry: CHSCO outperforms 45.98% of its industry peers.
CHSCO's Profit Margin has improved in the last couple of years.
CHSCO has a worse Operating Margin (0.02%) than 62.07% of its industry peers.
CHSCO's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 2.99%, CHSCO is doing worse than 88.51% of the companies in the same industry.
In the last couple of years the Gross Margin of CHSCO has remained more or less at the same level.
Industry RankSector Rank
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
CHSCO Yearly Profit, Operating, Gross MarginsCHSCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

3

2. Health

2.1 Basic Checks

CHSCO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CHSCO has a worse debt to assets ratio.
CHSCO Yearly Shares OutstandingCHSCO Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCO Yearly Total Debt VS Total AssetsCHSCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CHSCO has an Altman-Z score of 2.22. This is not the best score and indicates that CHSCO is in the grey zone with still only limited risk for bankruptcy at the moment.
CHSCO has a Altman-Z score (2.22) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.34 indicates that CHSCO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.34, CHSCO is in line with its industry, outperforming 59.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC0.01
WACC4.76%
CHSCO Yearly LT Debt VS Equity VS FCFCHSCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCO has a Current Ratio of 1.40. This is a normal value and indicates that CHSCO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CHSCO (1.40) is comparable to the rest of the industry.
A Quick Ratio of 0.86 indicates that CHSCO may have some problems paying its short term obligations.
CHSCO has a Quick ratio (0.86) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.86
CHSCO Yearly Current Assets VS Current LiabilitesCHSCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

3. Growth

3.1 Past

Looking at the last year, CHSCO shows a decrease in Revenue. The Revenue has decreased by -8.96% in the last year.
Measured over the past years, CHSCO shows a small growth in Revenue. The Revenue has been growing by 4.24% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCO Yearly Revenue VS EstimatesCHSCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCO Price Earnings VS Forward Price EarningsCHSCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHSCO is valued cheaply inside the industry as 90.80% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.78
CHSCO Per share dataCHSCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.75%, CHSCO is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.05, CHSCO pays a better dividend. On top of this CHSCO pays more dividend than 93.10% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, CHSCO pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.75%

5.2 History

CHSCO has paid a dividend for at least 10 years, which is a reliable track record.
CHSCO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
CHSCO Yearly Dividends per shareCHSCO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

32.94% of the earnings are spent on dividend by CHSCO. This is a low number and sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCO Yearly Income VS Free CF VS DividendCHSCO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
CHSCO Dividend Payout.CHSCO Dividend Payout, showing the Payout Ratio.CHSCO Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 7 7/8 PERP

NASDAQ:CHSCO (10/16/2025, 4:30:01 PM)

26.48

+0.04 (+0.15%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-09 2025-07-09
Earnings (Next)11-04 2025-11-04
Inst Owners11.67%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner Change0%
Market Cap324.91M
Analysts0
Price TargetN/A
Short Float %0.24%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield 6.75%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years4
Ex-Date09-16 2025-09-16 (0.492188)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.68
P/B 0.03
P/tB 0.03
EV/EBITDA 3.78
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY147.12%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROCE 0.07%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.05%
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
FCFM N/A
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexcg growth 3Y38.36%
ROICexcg growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 5.94
Cap/Depr 131.31%
Cap/Sales 2.22%
Interest Coverage 250
Cash Conversion 77.22%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.86
Altman-Z 2.22
F-Score3
WACC4.76%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%